# FDA recall D-147-2013

> **Mylan Pharmaceuticals Inc.** · Class II · drug recall initiated 2013-01-30.

## Product

Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.

## Reason for recall

Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-147-2013
- **Recalling firm:** Mylan Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-01-30
- **Report date:** 2013-02-13
- **Termination date:** 2013-12-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Morgantown, WV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-147-2013

## Citation

> AI Analytics. FDA recall D-147-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-147-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*